Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07602790 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Expand Management of Blood Pressure With Renal Denervation in Patients Undergoing Staged PCI for Advanced Coronary Artery diseasE

Study acronym: EMBRACE
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Ceric Sàrl
10 trials monitored
See 1 trial at risk
Heart Disease
8,786 trials monitored
See 412 trials at risk
Hypertension
1,925 trials monitored
See 99 trials at risk
Coronary Artery Disease
1,615 trials monitored
See 70 trials at risk
EMBRACE is a randomized, controlled, multicenter clinical study evaluating the effect of renal denervation on clinical adverse events in hypertensive patients undergoing staged percutaneous coronary intervention (PCI) for multivessel coronary artery disease.
Trial Details
NCT Number NCT07602790
Lead Sponsor Ceric Sàrl
Conditions
(from sponsor)		 Multivessel Coronary Artery Disease, Hypertension Resistant to Conventional Therapy
Related terms Hypertension Resistant to Conventional Therapy
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov